Journal
AMERICAN JOURNAL OF THE MEDICAL SCIENCES
Volume 322, Issue 4, Pages 209-212Publisher
LIPPINCOTT WILLIAMS & WILKINS
DOI: 10.1097/00000441-200110000-00011
Keywords
suppressive therapy; medical device-related infections
Categories
Funding
- PHS HHS [U50/CCU112346] Funding Source: Medline
Ask authors/readers for more resources
Background. Long-term suppressive antimicrobial therapy is an alternative treatment choice in patients with medical device-related infection who are not eligible for surgical device removal for attempted cure. There is a paucity of data published that examines this treatment option. Methods: Members of the Infectious Diseases Society of America's Emerging Infections Network were polled to identify patients with intravascular device-related infections who were not candidates for surgery and were given long-term antimicrobial therapy to suppress clinical manifestations of infection. Results: Clinical and microbiologic data were collected retrospectively for 51 patients. Sixty-nine percent of patients were men; vascular grafts were the most common type of medical device infected [30 (58.8%) patients]. Sixty-three percent (32 of 51) of cases involved Gram-positive cocci. A variety of antimicrobials were administered as chronic suppressive therapy, with beta -lactams used most frequently (39.2%). Therapy ranged from 3 months to 10 years. Three (7.32%) of 41 patients in whom follow-up data were available developed relapsing infection while on long-term suppressive therapy. Three other patients suffered drug adverse events. Conclusions: Overall, long-term suppressive therapy was well-tolerated and efficacious in preventing signs of infection relapse.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available